Login / Signup
Successful bridging to cell therapy for relapsed/refractory acute lymphoblastic leukaemia with a combination of venetoclax and PEG-asparaginase.
Laure Goursaud
Celine Berthon
Bruno Quesnel
Published in:
British journal of haematology (2022)
Keyphrases
</>
cell therapy
liver failure
acute lymphoblastic leukemia
stem cells
acute myeloid leukemia
mesenchymal stem cells
respiratory failure
multiple myeloma
diffuse large b cell lymphoma
hodgkin lymphoma
drug delivery
drug induced
aortic dissection
chronic lymphocytic leukemia
hepatitis b virus
mechanical ventilation